Source: Υπουργείο Υγείας (CY) Revision Year: 2018 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Felexin 125 mg/5 ml powder for oral suspension.
Felexin 250 mg/5 ml powder for oral suspension.
| Pharmaceutical Form |
|---|
|
Powder for oral suspension. Felexin 125 mg/5 ml powder for oral suspension: White powder that after reconstitution gives a pink, flavoured suspension. Felexin 250 mg/5 ml powder for oral suspension: White powder that after reconstitution gives an orange, flavoured suspension. |
Felexin 125 mg/5 ml powder for oral suspension: Each 5 ml of oral suspension contains cefalexin monohydrate equivalent to 125 mg cefalexin.
Felexin 250 mg/5 ml powder for oral suspension: Each 5 ml of oral suspension contains cefalexin monohydrate equivalent to 250 mg cefalexin.
Excipients with known effect:
Felexin 125 mg/5 ml powder for oral suspension: Each 5 ml of oral suspension contains 5 mg sodium benzoate, 0.4 mg carmoisine azorubine E122 and 1566.1 mg sucrose.
Felexin 250 mg/5 ml powder for oral suspension: Each 5 ml of oral suspension contains 5 mg sodium benzoate, 0.3 mg sunset yellow FCF E110 and 2151.3 mg sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Cefalexin |
Cefalexin is an antibacterial agent of the cephalosporin class. Like other cephalosporins cefalexin exerts antibacterial activity by binding to and inhibiting the action of penicillin-binding proteins involved in the synthesis of bacterial cell walls. This leads to bacterial cell lysis and cell death. |
| List of Excipients |
|---|
|
Felexin 125 mg/5 ml powder for oral suspension: Sodium Benzoate Felexin 250 mg/5 ml powder for oral suspension: Sodium Benzoate |
Amber glass bottles with aluminium closure. A measuring spoon of 5 ml (graduated every 2.5 ml) is supplied with this pack. Pack-size of 100 ml oral suspension.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Felexin 125 mg/5 ml powder for oral suspension: 19757
Felexin 250 mg/5 ml powder for oral suspension: 8572
Felexin 125 mg/5 ml powder for oral suspension:
Date of first authorization: 8 December 2005
Date of latest renewal: 12 September 2011
Felexin 250 mg/5 ml powder for oral suspension:
Date of first authorization: 29 December 1982
Date of latest renewal 16 March 2010
| Drug | Countries | |
|---|---|---|
| FELEXIN | Cyprus, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
